Delcath Systems

Delcath Systems

Yahoo Finance • 26 days ago

Keep Portfolio Volatility in Check With VLO, PBF, FET & DCTH

Uncertainty and fears continue to dominate the stock market as oil prices remain high, since the United States and Iran recently exchanged strikes. With the market expected to remain highly volatile, it is advisable for investors to increa... Full story

Yahoo Finance • 30 days ago

5 Stocks With Recent Price Strength Buoyed by a Strong August

U.S. stock markets ended August on a positive note after a mixed June and July. The Dow was up more than 1%, marking its fifth consecutive monthly winning streak. The S&P 500 and the Nasdaq Composite advanced 2.6% and 3.9%, respectively.... Full story

Yahoo Finance • 2 months ago

Delcath Systems Q2 Earnings Call Highlights

Key Points Interested in Delcath Systems, Inc.? Here are five stocks we like better. Revenue and outlook improved: Second-quarter revenue rose 20% year over year to $29.1 million, driven by a 30% increase in HEPZATO KIT volume. Delcath ra... Full story

Yahoo Finance • 5 months ago

Delcath Systems Q1 Earnings Call Highlights

Delcath Systems logo Delcath Systems (NASDAQ:DCTH) reported first-quarter 2026 revenue growth and reiterated its full-year outlook, while updating expectations for U.S. treatment-center activations and outlining progress across ongoing cl... Full story

Yahoo Finance • 7 months ago

Here are the major earnings before the open Thursday

Major earnings expected before the bell on Thursday include: * Viatris (VTRS [https://seekingalpha.com/symbol/VTRS]) * Baidu (BIDU [https://seekingalpha.com/symbol/BIDU]) * Vistance Networks (VISN [https://seekingalpha.com/symbol/VI... Full story

Yahoo Finance • 10 months ago

Here’s What Hit Delcath Systems (DCTH) in Q3

Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q3 2025 investor letter. A copy of the letter can be downloaded here. The strategy reported solid absolute returns in the quarter but lagged... Full story

Yahoo Finance • 11 months ago

H.C. Wainwright Reiterates a Buy on Delcath Systems (DCTH), Lowers the PT

​Delcath Systems, Inc. (NASDAQ:DCTH) is one of the Fast-Growing Small Cap Stocks to Buy According to Analysts. On November 5, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Delcath Systems, Inc. (NASDAQ:DCTH), but l... Full story

Yahoo Finance • 11 months ago

Delcath Systems reports $20.5M Q3 revenue, lowers FY revenue guidance

[Preliminary] moxiecreative Delcath Systems (NASDAQ:DCTH [https://seekingalpha.com/symbol/DCTH]) announced strong preliminary financial results [https://seekingalpha.com/pr/20270980-delcath-systems-announces-preliminary-third-quarter-2025... Full story

Yahoo Finance • 11 months ago

Here are the major earnings before the open Monday

Major earnings expected before the bell on Monday include: * Cleveland-Cliffs (CLF [https://seekingalpha.com/symbol/CLF]) * Dynex Capital (DX [https://seekingalpha.com/symbol/DX]) * Delcath Systems (DCTH [https://seekingalpha.com/sy... Full story

Yahoo Finance • last year

Invesco Backs Delcath Systems (DCTH) on Expansion Potential

Delcath Systems, Inc. (NASDAQ:DCTH) is among the fastest growing small cap stocks to buy. Invesco Ltd. has expanded its position in Delcath Systems, Inc. (NASDAQ:DCTH) through the acquisition of 399,389 shares of the company’s stock, as re... Full story

Yahoo Finance • last year

H.C. Wainwright Remains Bullish on Delcath Systems (DCTH)

Delcath Systems, Inc. (NASDAQ:DCTH) is one of the best medical device stocks to buy according to analysts. On August 6, H.C. Wainwright analyst Swayampakula Ramakanth maintained a bullish stance on Delcath Systems, Inc. (NASDAQ:DCTH), givi... Full story

Yahoo Finance • last year

Delcath outlines 175% projected HEPZATO volume growth and targets up to 28 operational centers by year-end 2025 amid expanding clinical pipeline

Earnings Call Insights: Delcath Systems (DCTH) Q2 2025 MANAGEMENT VIEW * Gerard J. Michel, CEO, highlighted, "Quarterly revenue reached $24.2 million, an increase of over 20% compared to the first quarter of 2025, reflecting continued... Full story

Yahoo Finance • last year

Delcath Systems GAAP EPS of $0.07 beats by $0.05, revenue of $24.2M beats by $1.18M

* Delcath Systems press release [https://seekingalpha.com/pr/20190883-delcath-systems-reports-second-quarter-2025-results-and-business-highlights] (NASDAQ:DCTH [https://seekingalpha.com/symbol/DCTH]): Q2 GAAP EPS of $0.07 beats by $0.05.... Full story

Yahoo Finance • 2 years ago

Beta Bionics Announces Board Appointment of Gerard Michel

IRVINE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced the appointment of Gerard Michel as an independent me... Full story

Yahoo Finance • 4 years ago

Delcath Systems Reports First Quarter 2022 Results and Provides Business Update

NEW YORK , May 10, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business highlights and financia... Full story

Yahoo Finance • 4 years ago

Delcath Systems to Participate in the Canaccord Genuity Horizons in Oncology Conference

NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will participate in the Canaccord Genuity Hori... Full story

Yahoo Finance • 5 years ago

Delcath Systems to Participate in the Lytham Partners Spring 2022 Investor Conference

NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today that it will be participating... Full story

Yahoo Finance • 5 years ago

Delcath Systems Reports Fourth Quarter and Full-Year 2021 Results and Provides Business Update

NEW YORK, March 25, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business highlights and financi... Full story